LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 3 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,881 | +226.6% | 281,094 | +235.7% | 0.01% | +200.0% |
Q2 2023 | $5,781 | -46.4% | 83,737 | -62.5% | 0.00% | -20.0% |
Q1 2023 | $10,779 | -57.1% | 223,538 | -55.6% | 0.01% | -58.3% |
Q4 2022 | $25,123 | -99.8% | 503,254 | +67.1% | 0.01% | -7.7% |
Q3 2022 | $12,289,000 | -23.7% | 301,212 | +2.8% | 0.01% | +30.0% |
Q2 2022 | $16,111,000 | +80.7% | 292,912 | +19.4% | 0.01% | +42.9% |
Q1 2022 | $8,915,000 | – | 245,326 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |